视网膜血管炎的临床结局及缺血性视网膜血管炎预后预测因素
回顾性队列研究纳入英国伦敦Moorfields眼科医院1169例葡萄膜炎患者,视网膜血管炎见于236眼(缺血性121眼、非缺血性115眼),并与1022眼无视网膜血管炎对照组比较。视网膜血管炎组视力丧失风险显著高于对照组(HR 1.67,95%CI 1.24-2.25,P=.001),黄斑缺血使视力丧失风险增加4.4倍,全身泼尼松龙与视力丧失风险降低相关(HR 0.36,95%CI 0.15-0.82,P=.01)。缺血累及≥2个象限是新血管形成危险因素(HR 2.7,95%CI 1.3-5.5,P=.003)。
要点
- 视网膜血管炎组视力丧失风险显著高于无血管炎组(HR 1.67,95%CI 1.24-2.25,P=.001)。
- 黄斑缺血使血管炎眼视力丧失风险增加4.4倍,黄斑水肿风险约为无血管炎组的2倍。
- 缺血累及≥2个象限与新血管形成风险升高相关(HR 2.7,95%CI 1.3-5.5,P=.003)。
核心结论
- 视网膜血管炎与视力丧失风险增加相关,主要继发于黄斑缺血,且黄斑水肿风险高于无血管炎眼。
- 缺血累及≥2个象限是新血管形成的危险因素。
研究设计与样本
- 回顾性队列研究,复习英国伦敦Moorfields眼科医院1169例葡萄膜炎患者。
- 视网膜血管炎见于236眼(缺血性121眼、非缺血性115眼),与1022眼无视网膜血管炎对照组比较。
- 对63眼缺血性血管炎行超广角荧光素眼底血管造影,以缺血指数定量无灌注区面积。
主要发现
- 视网膜血管炎组视力丧失风险显著高于无血管炎组(HR 1.67,95%CI 1.24-2.25,P=.001)。
- 视网膜血管炎组黄斑水肿风险为无血管炎组的2倍。
- 黄斑缺血使血管炎眼视力丧失风险增加4.4倍。
- 血管炎眼使用全身泼尼松龙与视力丧失风险降低相关(HR 0.36,95%CI 0.15-0.82,P=.01)。
- 75眼(62.0%)接受激光光凝,其中29眼(38.1%)出现新生血管复发并需追加激光治疗;缺血指数中位数25.8%(四分位距10.2%-46%)。
关键数值与推荐
- 缺血累及≥2个象限与新血管形成风险升高相关(HR 2.7,95%CI 1.3-5.5,P=.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine factors affecting the visual outcome in eyes with retinal vasculitis and the rate of neovascularization relapse in ischemic vasculitis. DESIGN: Retrospective cohort study. METHODS: We reviewed 1169 uveitis patients from Moorfields Eye Hospital, London, UK. Retinal vasculitis was observed in 236 eyes (121 ischemic, 115 nonischemic) that were compared with a control group (1022 eyes) with no retinal vasculitis. Ultra-widefield fluorescein angiography images were obtained in 63 eyes with ischemic vasculitis to quantify area of nonperfusion measured as ischemic index. RESULTS: The risk of vision loss was significantly more in the retinal vasculitis compared with the non-vasculitis group (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.24-2.25, P = .001). Retinal vasculitis had twice the risk of macular edema compared to the non-vasculitis group. Macular ischemia increased the risk of vision loss in vasculitis eyes by 4.4 times. The use of systemic prednisolone in eyes with vasculitis was associated with a reduced risk of vision loss (HR 0.36, 95% CI 0.15-0.82, P = .01). Laser photocoagulation was administered in 75 eyes (62.0%), out of which 29 (38.1%) had new vessel relapse and required additional laser treatment. The median ischemic index was 25.8% (interquartile range 10.2%-46%). Ischemia involving ≥2 quadrants was associated with increased risk of new vessel formation (HR 2.7, 95% CI 1.3-5.5, P = .003). CONCLUSIONS: Retinal vasculitis is associated with an increased risk of vision loss, mainly secondary to macular ischemia, and has a higher risk of macular edema compared to eyes with no vasculitis. Ischemia involving ≥2 quadrants is a risk factor for new vessel formation.
引用
- Sharief L, Lightman S, Blum-Hareuveni T, et al. Clinical Outcome of Retinal Vasculitis and Predictors for Prognosis of Ischemic Retinal Vasculitis. Am J Ophthalmol. 2017. PMID: 28263735. doi:10.1016/j.ajo.2017.02.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。